Onkologie. 2013:7(5):239-241
Supportive care in oncology: stimulation of white blood cells
- KOC FN Plzeň
The common side effect of majority of chemotherapy regimens is neutropenia and fibrile neutropenia. Risk of infection development
and need of hospitál admission or antibiotik use can be reduces by G-CSF administration. All evaluated characteristics including cost-
-effectivity, possibility of full chemotherapy dose administration and even better short-term outcome as far as lower mortality give
preference for pegfilgrastim over filgrastim. Definitely, primary rather than secondary prophylaxis should be favoured.
Keywords: neutropenia/febrile neutropenia, pegfilgrastim, filgrastim, cost-effectivity, primary vs. secondary prophylaxis
Published: November 1, 2013 Show citation
